Specialty Nutrients
Neptune, Acasti Unable to Reach Final Settlement with Enzymotec
Legal ComplianceNeptune, Acasti Unable to Reach Final Settlement with EnzymotecNeptune, Acasti Unable to Reach Final Settlement with Enzymotec
Neptune Technologies & Bioressources Inc. and Acasti Pharma Inc., a subsidiary of Neptune, announced they were unable to reach a final settlement agreement through mediation with Enzymotec Ltd. and Enzymotec USA, Inc. that would resolve an investigation into infringement of Neptune’s composition of matter patents.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.